Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02148809 · ClinicalTrials.gov registry record · NA
Blood Volume Analysis of Total Hip Arthroplasty Patients Under Hypotensive Anesthesia
A NA study, sponsored by Hospital for Special Surgery, New York.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT02148809 is a NA study that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 14 participants.
The verdict
NCT02148809, a NA study, has completed, sponsored by Hospital for Special Surgery, New York.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
Hypotensive Anesthesia is a type of regional anesthesia performed routinely at our hospital. This type of anesthesia reduces the average arterial pressure. Benefits include reduced bleeding and lower risk of blood clots. The purpose of this study is to determine the effect of intravenous fluids administered with hypotensive anesthesia on your blood volume. With this parameter we will be able to understand how much of your blood is lost because of bleeding and how much of the drop is related to dilution. Study hypothesis: Hemodilution associated with intravenous fluid substitution during hypotensive anesthesia results in decreased postoperative hemoglobin (Hb) levels
Interventions
- RADIATION 1mL of I-131 Human Serum Albumin is injected prior to the measurements
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2014-05 |
| Est. Completion | 2016-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02148809
The ClinicalTrials.gov registry entry for NCT02148809 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 1mL of I-131 Human Serum Albumin is injected prior to the measurements is the first listed.
NCT02148809 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02148809 about?
NCT02148809 is a clinical study titled "Blood Volume Analysis of Total Hip Arthroplasty Patients Under Hypotensive Anesthesia". Hypotensive Anesthesia is a type of regional anesthesia performed routinely at our hospital. This type of anesthesia reduces the average arterial pressure. Benefits include reduced bleeding and lower risk of blood clots. The purpose of this study is to determine the effect of intravenous fluids adm...
What is the current status of trial NCT02148809?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2014-05. Estimated completion is 2016-07.
What interventions are being tested in trial NCT02148809?
The interventions under investigation include: 1mL of I-131 Human Serum Albumin is injected prior to the measurements (RADIATION).
Who is sponsoring clinical trial NCT02148809?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.